Hematology Market Outlook 2030 | Industry Trends and Competitive Analysis

Global Hematology Market Overview

The global hematology market is projected to grow at a CAGR of approximately 3–5% through 2027. Key drivers of this growth include the rising prevalence of coagulation and blood-related disorders, increased blood donation activities, expanding adoption of point-of-care (POC) diagnostics for home-based testing, continuous technological innovations in hematology analyzers and reagents, broader use of flow cytometry in hematology, and the market’s recovery following the COVID-19 pandemic.

Strategic Insights Made Affordable — Limited Period Year-End Offers Now Live

Hematology is a medical specialty focused on the study of blood, blood-forming organs, and related disorders. It encompasses a wide range of benign and malignant conditions affecting red blood cells, white blood cells, platelets, and the coagulation system in both adults and children. Hematology specialists are involved in the research, diagnosis, and treatment of conditions such as anemia, hemophilia and other bleeding disorders, blood clots, sickle cell disease, and hematological malignancies including leukemia, lymphoma, and myeloma.

Impact of COVID-19 on the Global Hematology Market

The COVID-19 pandemic had a positive impact on the hematology market, as hematological parameters became critical for assessing and managing COVID-19 patients worldwide. Demand for hematology analyzers increased significantly, as these systems were widely used for tests such as complete blood counts, blood level measurements, and detailed blood sample analyses.

Since the lungs were the primary organs affected by COVID-19, hematology testing played an essential role in monitoring red blood cell (RBC) counts and oxygen transport. Damage to the alveoli disrupted gas exchange, impairing the ability of red blood cells to carry oxygen. As a result, hematology tests became vital for evaluating disease severity and patient outcomes during the pandemic.

Technological Advancements Driving Market Growth

Ongoing technological innovation remains a major force propelling the global hematology market. Manufacturers continue to introduce advanced analyzers that improve workflow efficiency, accuracy, and throughput in laboratories.

For example, in May 2023, Siemens Healthineers launched the next-generation Atellica HEMA 570 and Atellica HEMA 580 analyzers, designed for high-volume testing with intuitive user interfaces and enhanced automation connectivity. Similarly, in July 2022, HORIBA Medical expanded its Yumizen H500 and H550 product family with compact benchtop analyzers offering improved performance, new functionalities, and added value for laboratories.

As highlighted by a director at a leading U.S.-based hematology analyzer manufacturer, the increasing incidence of blood disorders, rapid technological advancements, and the ongoing digital transformation of hematology laboratories are key growth drivers. In the European Union alone, an estimated 80 million people are affected by blood disorders.

Download Sample Copy: https://meditechinsights.com/global-hematology-market/request-sample/

AI-Powered Hematology Analyzers Enhancing Diagnostic Capabilities

Traditional hematology analyzers often provide limited diagnostic insights, while the growing volume of laboratory data can overwhelm clinicians. AI-powered automatic hematology analyzers address this challenge by applying artificial intelligence to convert complex data into clinically meaningful insights. These systems help reduce turnaround times, minimize misclassifications, and lower the workload for healthcare professionals.

An example is the DH-615 hematology analyzer from Dymind Biotechnology, which combines fluorescent nucleic acid staining with the company’s proprietary AI Cube technology. By integrating 6-DIFF with reticulocyte (RET) analysis, the system significantly improves abnormal cell detection and enhances the assessment of hematological diseases.

Browse Report: https://meditechinsights.com/global-hematology-market/

Competitive Landscape of the Hematology Market

The global hematology market is highly competitive, with the presence of several established players, including:

• Sysmex Corporation
• Beckman Coulter (Danaher Corporation)
• Siemens Healthineers
• Abbott
• Mindray
• Nihon Kohden
• Boule Diagnostics
• Bio-Rad Laboratories
• HORIBA
• Drew Scientific

Growth Strategies Adopted by Market Leaders

Leading companies in the hematology market employ a combination of organic and inorganic growth strategies, such as new product launches, partnerships, and collaborations, to strengthen their market position.

For instance, in July 2022, Beckman Coulter partnered with Scopio Labs to accelerate the adoption of digital cell morphology platforms in hematology. In March 2022, Mindray introduced the BC-700 Series, a compact and integrated CBC and ESR hematology analyzer designed for small- to mid-sized laboratories.

Related Report:

• Nanomedicine Market - https://www.pharmiweb.com/press-release/2025-12-04/nanomedicine-market-insights-and-growth-opportunities-in-2025-an-extensive-analysis-2030
• Alzheimer’s Drugs Market - https://www.pharmiweb.com/press-release/2025-12-04/weight-management-market-trends-investment-opportunities-and-growth-analysis-through-2030
• Healthcare Cloud Computing Market - https://www.pharmiweb.com/press-release/2025-12-04/healthcare-cloud-computing-market-set-to-witness-significant-growth-by-2025-2030
• Weight Management Market - https://www.pharmiweb.com/press-release/2025-12-04/weight-management-market-trends-investment-opportunities-and-growth-analysis-through-2030

About Medi-Tech Insights;

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com